{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:39:50Z","timestamp":1792571990977,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T00:00:00Z","timestamp":1788652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T00:00:00Z","timestamp":1788652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3503100, 2023YFC3503103"],"award-info":[{"award-number":["2023YFC3503100, 2023YFC3503103"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05720-w","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T09:15:21Z","timestamp":1788686121000},"page":"5301-5317","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ellagic acid attenuates myocardial fibrosis by suppressing Bmi1-mediated inhibition of the p53\/p21 pathway in cardiac fibroblasts"],"prefix":"10.1007","volume":"481","author":[{"given":"Bolin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyu","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengsi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HaiTong","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,6]]},"reference":[{"key":"5720_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu SD, Frangogiannis NG (2016) The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res 119:91\u2013112","journal-title":"Circ Res"},{"key":"5720_CR2","doi-asserted-by":"publisher","first-page":"7143","DOI":"10.1016\/j.cell.2024.09.034","volume":"187","author":"H Zhang","year":"2024","unstructured":"Zhang H, Thai PN, Shivnaraine RV, Ren L, Wu X, Siepe DH, Liu Y, Tu C, Shin HS, Caudal A et al (2024) Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target. Cell 187:7143\u20137163","journal-title":"Cell"},{"key":"5720_CR3","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","volume":"71","author":"P Kong","year":"2014","unstructured":"Kong P, Christia P, Frangogiannis NG (2014) The pathogenesis of cardiac fibrosis. Cell Mol Life Sci 71:549\u2013574","journal-title":"Cell Mol Life Sci"},{"key":"5720_CR4","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s11427-023-2452-2","volume":"67","author":"S Yuan","year":"2024","unstructured":"Yuan S, Zhang X, Zhan J, Xie R, Fan J, Dai B, Zhao Y, Yin Z, Liu Q, Wang DW et al (2024) Fibroblast-localized lncRNA CFIRL promotes cardiac fibrosis and dysfunction in dilated cardiomyopathy. Sci China-Life Sci 67:1155\u20131169","journal-title":"Sci China-Life Sci"},{"key":"5720_CR5","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1093\/cvr\/cvab340","volume":"118","author":"F Hubert","year":"2022","unstructured":"Hubert F, Payan SM, Pelce E, Bouchard L, Sturny R, Lenfant N, Mottola G, Collart F, Kelly RG, Rochais F (2022) FGF10 promotes cardiac repair through a dual cellular mechanism increasing cardiomyocyte renewal and inhibiting fibrosis. Cardiovasc Res 118:2625\u20132637","journal-title":"Cardiovasc Res"},{"key":"5720_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1161\/CIRCRESAHA.121.320324","volume":"133","author":"X Liu","year":"2023","unstructured":"Liu X, Burke RM, Lighthouse JK, Baker CD, Dirkx RJ, Kang B, Chakraborty Y, Mickelsen DM, Twardowski JJ, Mello SS et al (2023) p53 regulates the extent of fibroblast proliferation and fibrosis in left ventricle pressure overload. Circ Res 133:271\u2013287","journal-title":"Circ Res"},{"key":"5720_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52739-y","volume":"15","author":"S Li","year":"2024","unstructured":"Li S, Yang M, Zhao Y, Zhai Y, Sun C, Guo Y, Zhang X, Zhang L, Tian T, Yang Y et al (2024) Deletion of ASPP1 in myofibroblasts alleviates myocardial fibrosis by reducing p53 degradation. Nat Commun 15:8425","journal-title":"Nat Commun"},{"key":"5720_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155659","volume":"130","author":"T Fang","year":"2024","unstructured":"Fang T, Wang J, Sun S, Deng X, Xue M, Han F, Sun B, Chen L (2024) JinLiDa granules alleviates cardiac hypertrophy and inflammation in diabetic cardiomyopathy by regulating TP53. Phytomedicine 130:155659","journal-title":"Phytomedicine"},{"key":"5720_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216921","volume":"592","author":"Y Song","year":"2024","unstructured":"Song Y, Lian S, Fan H, Ma C, Zheng L, Huang F, Huang S, Tang Y, Shi A, Shu L et al (2024) Bmi1 facilitates the progression of cholangiocarcinoma by inhibiting Foxn2 expression dependent on a histone H2A ubiquitination manner. Cancer Lett 592:216921","journal-title":"Cancer Lett"},{"key":"5720_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103193","volume":"63","author":"D Yang","year":"2021","unstructured":"Yang D, Liu HQ, Yang Z, Fan D, Tang QZ (2021) BMI1 in the heart: novel functions beyond tumorigenesis. EBioMedicine 63:103193","journal-title":"EBioMedicine"},{"key":"5720_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.574","volume":"12","author":"H Chen","year":"2022","unstructured":"Chen H, Zhou J, Chen H, Liang J, Xie C, Gu X, Wang R, Mao Z, Zhang Y, Li Q et al (2022) Bmi-1-RING1B prevents GATA4-dependent senescence-associated pathological cardiac hypertrophy by promoting autophagic degradation of GATA4. Clin Transl Med 12:e574","journal-title":"Clin Transl Med"},{"key":"5720_CR12","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.3390\/biom5043396","volume":"5","author":"X Lin","year":"2015","unstructured":"Lin X, Ojo D, Wei F, Wong N, Gu Y, Tang D (2015) A novel aspect of tumorigenesis-BMI1 functions in regulating DNA damage response. Biomolecules 5:3396\u20133415","journal-title":"Biomolecules"},{"key":"5720_CR13","doi-asserted-by":"publisher","first-page":"H61","DOI":"10.1152\/ajpheart.00487.2018","volume":"316","author":"W Yang","year":"2019","unstructured":"Yang W, Wu Z, Yang K, Han Y, Chen Y, Zhao W, Huang F, Jin Y, Jin W (2019) BMI1 promotes cardiac fibrosis in ischemia-induced heart failure via the PTEN-PI3K\/Akt-mTOR signaling pathway. Am J Physiol -Heart Circul Physiol 316:H61\u2013H69","journal-title":"Am J Physiol -Heart Circul Physiol"},{"key":"5720_CR14","first-page":"655","volume":"37","author":"W Yang","year":"2021","unstructured":"Yang W, Zhang A, Han Y, Su X, Chen Y, Zhao W, Yang K, Jin W (2021) Cyclin-dependent kinase inhibitor 2b controls fibrosis and functional changes in ischemia-induced heart failure via the BMI1-p15-Rb signalling pathway. Can J Cardiol 37:655\u2013664","journal-title":"Can J Cardiol"},{"key":"5720_CR15","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.biopha.2017.07.106","volume":"95","author":"DZ Wei","year":"2017","unstructured":"Wei DZ, Lin C, Huang YQ, Wu LP, Huang MY (2017) Ellagic acid promotes ventricular remodeling after acute myocardial infarction by up-regulating miR-140-3p. Biomed Pharmacother 95:983\u2013989","journal-title":"Biomed Pharmacother"},{"key":"5720_CR16","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.3390\/ijms21103526","volume":"21","author":"M Yousuf","year":"2020","unstructured":"Yousuf M, Shamsi A, Khan P, Shahbaaz M, AlAjmi MF, Hussain A, Hassan GM, Islam A, Rizwanul HQ, Hassan MI (2020) Ellagic acid controls cell proliferation and induces apoptosis in breast cancer cells via inhibition of cyclin-dependent kinase 6. Int J Mol Sci 21:3526","journal-title":"Int J Mol Sci"},{"key":"5720_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154867","volume":"116","author":"J Li","year":"2023","unstructured":"Li J, Liao R, Zhang S, Weng H, Liu Y, Tao T, Yu F, Li G, Wu J (2023) Promising remedies for cardiovascular disease: natural polyphenol ellagic acid and its metabolite urolithins. Phytomedicine 116:154867","journal-title":"Phytomedicine"},{"key":"5720_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2026.157783","volume":"151","author":"W Huang","year":"2026","unstructured":"Huang W, Wang X, Yan X, Wang S, Lin L, Li L, Liu L, Wang Y, Li X, Mao Y et al (2026) Anacardic acid mitigates post\u2011MI cardiac fibrosis via suppressing p38\/JNK-GATA3 pathway and H3K9ac\u2011dependent epigenetic regulation. Phytomedicine 151:157783","journal-title":"Phytomedicine"},{"key":"5720_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cells13050421","author":"P Azeredo","year":"2024","unstructured":"Azeredo P, Fan D, Murphy EA, Carver WE (2024) Potential of plant-derived compounds in preventing and reversing organ fibrosis and the underlying mechanisms. Cells. https:\/\/doi.org\/10.3390\/cells13050421","journal-title":"Cells"},{"key":"5720_CR20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s13318-022-00777-6","volume":"47","author":"Y Yang","year":"2022","unstructured":"Yang Y, Yang J, Fu W, Zhou P, He Y, Fang M, Wan H, Zhou H (2022) Pharmacokinetic comparison of nine bioactive compounds of Guanxinshutong capsule in normal and acute myocardial infarction rats. Eur J Drug Metabol Pharmacokinet 47:653\u2013665","journal-title":"Eur J Drug Metabol Pharmacokinet"},{"key":"5720_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41392-024-01816-1","volume":"9","author":"F Peng","year":"2024","unstructured":"Peng F, Liao M, Jin W, Liu W, Li Z, Fan Z, Zou L, Chen S, Zhu L, Zhao Q et al (2024) 2-APQC, a small-molecule activator of Sirtuin-3 (SIRT3), alleviates myocardial hypertrophy and fibrosis by regulating mitochondrial homeostasis. Signal Transduct Target Ther 9:133","journal-title":"Signal Transduct Target Ther"},{"key":"5720_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111101","volume":"134","author":"F Keihanian","year":"2021","unstructured":"Keihanian F, Moohebati M, Saeidinia A, Mohajeri SA, Madaeni S (2021) Therapeutic effects of medicinal plants on isoproterenol-induced heart failure in rats. Biomed Pharmacother 134:111101","journal-title":"Biomed Pharmacother"},{"key":"5720_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.metabol.2012.06.003","volume":"62","author":"MM Kannan","year":"2013","unstructured":"Kannan MM, Quine SD (2013) Ellagic acid inhibits cardiac arrhythmias, hypertrophy and hyperlipidaemia during myocardial infarction in rats. Metab -Clin Exp 62:52\u201361","journal-title":"Metab -Clin Exp"},{"key":"5720_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156588","volume":"141","author":"G Ge","year":"2025","unstructured":"Ge G, Zhao W, Zhong Z, Huang Y, Hua Y, Chen K, Yu Y, Wu T, Lu Y, Yadav N et al (2025) Acacetin ameliorates pressure overload-induced cardiac remodeling by targeting USP10 and inhibiting maladaptive cardiomyocyte autophagy. Phytomedicine 141:156588","journal-title":"Phytomedicine"},{"key":"5720_CR25","volume":"12","author":"KJ Chen","year":"2025","unstructured":"Chen KJ, Zhang Y, Zhu XY, Yu S, Xie Y, Jin CJ, Shen YM, Zhou SY, Dai XC, Su SA et al (2025) GSTM1 suppresses cardiac fibrosis post-myocardial infarction through inhibiting lipid peroxidation and ferroptosis. Mil Med Res 12:26","journal-title":"Mil Med Res"},{"key":"5720_CR26","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.freeradbiomed.2022.08.016","volume":"190","author":"H Yao","year":"2022","unstructured":"Yao H, He Q, Huang C, Wei S, Gong Y, Li X, Liu W, Xu Z, Wu H, Zheng C et al (2022) Panaxatriol saponin ameliorates myocardial infarction-induced cardiac fibrosis by targeting Keap1\/Nrf2 to regulate oxidative stress and inhibit cardiac-fibroblast activation and proliferation. Free Radic Biol Med 190:264\u2013275","journal-title":"Free Radic Biol Med"},{"key":"5720_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713169","author":"S Sun","year":"2023","unstructured":"Sun S, Gong D, Liu R, Wang R, Chen D, Yuan T, Wang S, Xing C, Lv Y, Du G et al (2023) Puerarin inhibits NLRP3-caspase-1-GSDMD-mediated pyroptosis via P2X7 receptor in cardiomyocytes and macrophages. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241713169","journal-title":"Int J Mol Sci"},{"key":"5720_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114169","volume":"275","author":"Y Pan","year":"2021","unstructured":"Pan Y, Shao C, Zhang L, He Y, Yang J, Fu W, Yang J, Wan H (2021) The effect of Guanxin Shutong capsule on alleviating the myocardial fibrosis in heart failure rats. J Ethnopharmacol 275:114169","journal-title":"J Ethnopharmacol"},{"key":"5720_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116000","volume":"170","author":"L Qian","year":"2024","unstructured":"Qian L, Xu H, Yuan R, Yun W, Ma Y (2024) Formononetin ameliorates isoproterenol induced cardiac fibrosis through improving mitochondrial dysfunction. Biomed Pharmacother 170:116000","journal-title":"Biomed Pharmacother"},{"key":"5720_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1074248420952233","volume":"26","author":"W Cheng","year":"2021","unstructured":"Cheng W, Li X, Liu D, Cui C, Wang X (2021) Endothelial-to-mesenchymal transition: role in cardiac fibrosis. J Cardiovasc Pharmacol Ther 26:3\u201311","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"5720_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10741-018-9720-1","volume":"24","author":"E Tarbit","year":"2019","unstructured":"Tarbit E, Singh I, Peart JN (2019) Rose\u2019Meyer, R. B. Biomarkers for the identification of cardiac fibroblast and myofibroblast cells. Heart Fail Rev 24:1\u201315","journal-title":"Heart Fail Rev"},{"key":"5720_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.141400","volume":"306","author":"R Rong","year":"2025","unstructured":"Rong R, Yuan T, Yan Z, Tan L, Wei X, Li G, Gao H, Zhang J, Zhao X, Zhang Z et al (2025) LncRNA NAV2-AS2 is critical for fibroblast-to-myofibroblast transition and cardiac fibrosis. Int J Biol Macromol 306:141400","journal-title":"Int J Biol Macromol"},{"key":"5720_CR33","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1016\/j.bbamcr.2015.05.026","volume":"1853","author":"X Huang","year":"2015","unstructured":"Huang X, Zhang S, Qi H, Wang Z, Chen HW, Shao J, Shen J (2015) JMJD5 interacts with p53 and negatively regulates p53 function in control of cell cycle and proliferation. Biochim Biophys Acta 1853:2286\u20132295","journal-title":"Biochim Biophys Acta"},{"key":"5720_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.31083\/j.rcm2302060","volume":"23","author":"L Xu","year":"2022","unstructured":"Xu L, Chen L, Gu G, Wang Y, Xu Y, Zhong Y (2022) Natural products from traditional Chinese medicine for the prevention and treatment of heart failure: progress and perspectives. Rev Cardiovasc Med 23:60","journal-title":"Rev Cardiovasc Med"},{"key":"5720_CR35","doi-asserted-by":"publisher","first-page":"114666","DOI":"10.1016\/j.biopha.2023.114666","volume":"162","author":"F Mannino","year":"2023","unstructured":"Mannino F, Imbesi C, Bitto A, Minutoli L, Squadrito F, D\u2019Angelo T, Booz C, Pallio G, Irrera N (2023) Anti-oxidant and anti-inflammatory effects of ellagic and punicic acid in an in vitro model of cardiac fibrosis. Biomed Pharmacother 162:114666","journal-title":"Biomed Pharmacother"},{"key":"5720_CR36","doi-asserted-by":"publisher","first-page":"18083","DOI":"10.1021\/acsomega.3c10009","volume":"9","author":"Y Liu","year":"2024","unstructured":"Liu Y, Li Q, Shao C, She Y, Zhou H, Guo Y, An H, Wang T, Yang J, Wan H (2024) Exploring the potential mechanisms of Guanxinshutong capsules in treating pathological cardiac hypertrophy based on network pharmacology, computer-aided drug design, and animal experiments. Acs Omega 9:18083\u201318098","journal-title":"Acs Omega"},{"key":"5720_CR37","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.addr.2021.03.021","volume":"173","author":"M Liu","year":"2021","unstructured":"Liu M, L\u00f3pez DJAB, Cheng K (2021) Cardiac fibrosis: myofibroblast-mediated pathological regulation and drug delivery strategies. Adv Drug Deliv Rev 173:504\u2013519","journal-title":"Adv Drug Deliv Rev"},{"key":"5720_CR38","first-page":"1091","volume":"44","author":"Q Xiao","year":"2019","unstructured":"Xiao Q, Zhao XY, Jiang RC, Chen XH, Zhu X, Chen KF, Chen SY, Zhang XL, Qin Y, Liu YH et al (2019) Increased expression of Sonic hedgehog restores diabetic endothelial progenitor cells and improves cardiac repair after acute myocardial infarction in diabetic mice. Int J Mol Med 44:1091\u20131105","journal-title":"Int J Mol Med"},{"key":"5720_CR39","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/cvr\/cvae210","volume":"120","author":"I Tuleta","year":"2024","unstructured":"Tuleta I, Hanna A, Humeres C, Aguilan JT, Sidoli S, Zhu F, Frangogiannis NG (2024) Fibroblast-specific TGF-\u03b2 signaling mediates cardiac dysfunction, fibrosis, and hypertrophy in obese diabetic mice. Cardiovasc Res 120:2047\u20132063","journal-title":"Cardiovasc Res"},{"key":"5720_CR40","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jare.2024.01.012","volume":"67","author":"Q Mao","year":"2025","unstructured":"Mao Q, Zhang X, Yang J, Kong Q, Cheng H, Yu W, Cao X, Li Y, Li C, Liu L et al (2025) HSPA12A acts as a scaffolding protein to inhibit cardiac fibroblast activation and cardiac fibrosis. J Adv Res 67:217\u2013229","journal-title":"J Adv Res"},{"key":"5720_CR41","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jacep.2017.03.002","volume":"3","author":"S Nattel","year":"2017","unstructured":"Nattel S (2017) Molecular and cellular mechanisms of atrial fibrosis in atrial fibrillation. Jacc-Clin Electrophysiol 3:425\u2013435","journal-title":"Jacc-Clin Electrophysiol"},{"key":"5720_CR42","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41419-021-03925-z","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Oh M, Sasaki JI, N\u00f6r JE (2021) Inverse and reciprocal regulation of p53\/p21 and Bmi-1 modulates vasculogenic differentiation of dental pulp stem cells. Cell Death Dis 12:644","journal-title":"Cell Death Dis"},{"key":"5720_CR43","doi-asserted-by":"publisher","first-page":"9134","DOI":"10.1074\/jbc.RA118.006000","volume":"294","author":"Y Guo","year":"2019","unstructured":"Guo Y, Lei I, Tian S, Gao W, Hacer K, Li Y, Wang S, Liu L, Wang Z (2019) Chemical suppression of specific C-C chemokine signaling pathways enhances cardiac reprogramming. J Biol Chem 294:9134\u20139146","journal-title":"J Biol Chem"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05720-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05720-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05720-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:55:44Z","timestamp":1792569344000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05720-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,6]]},"references-count":43,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["5720"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05720-w","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,6]]},"assertion":[{"value":"20 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}